Lehman & Derafelo Financial Resources’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-300
| Closed | -$18K | – | 161 |
|
2022
Q3 | $18K | Hold |
300
| – | – | 0.01% | 149 |
|
2022
Q2 | $17K | Buy |
+300
| New | +$17K | 0.01% | 156 |
|
2021
Q4 | – | Sell |
-300
| Closed | -$22K | – | 159 |
|
2021
Q3 | $22K | Hold |
300
| – | – | 0.01% | 151 |
|
2021
Q2 | $23K | Hold |
300
| – | – | 0.01% | 175 |
|
2021
Q1 | $22K | Sell |
300
-300
| -50% | -$22K | 0.01% | 174 |
|
2020
Q4 | $42K | Hold |
600
| – | – | 0.01% | 152 |
|
2020
Q3 | $34K | Hold |
600
| – | – | 0.01% | 147 |
|
2020
Q2 | $35K | Hold |
600
| – | – | 0.01% | 134 |
|
2020
Q1 | $28K | Hold |
600
| – | – | 0.01% | 128 |
|
2019
Q4 | $34K | Hold |
600
| – | – | 0.01% | 145 |
|
2019
Q3 | $28K | Hold |
600
| – | – | 0.01% | 137 |
|
2019
Q2 | $32K | Hold |
600
| – | – | 0.01% | 134 |
|
2019
Q1 | $33K | Hold |
600
| – | – | 0.01% | 136 |
|
2018
Q4 | $28K | Buy |
+600
| New | +$28K | 0.01% | 128 |
|